41 Years of Experience
Who is Dr. Bernstein, Pediatric Cardiologist in Palo Alto, CA?
Dr. Daniel Bernstein, MD is a Pediatric Cardiologist, who primarily practices in Palo Alto, CA. He has been practicing for over 41 years and is board certified. Dr. Bernstein graduated from New York University School of Medicine and completed his residency at Univ Ca Sf Sch Of Med, Pediatrics; Montefiore M C-H&l Moses Div, Pediatrics. Dr. Bernstein is fluent in English, Chinese, Korean, Spanish, Tagalog, and Vietnamese, and is currently seeing new patients. Dr. Bernstein’s practice accepts Kaiser Permanente, Medicare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Bernstein’s office at (650) 497-8000.
What are Areas of Expertise for Dr. Bernstein?
Dr. Daniel Bernstein, MD is a highly-rated, board-certified Pediatric Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Bernstein empowers patients to confidently navigate their health journey, specializing in Heart Failure, Transplant Medicine-Heart, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Bernstein is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Bernstein go to medical school and complete their residency?
Residency: Univ Ca Sf Sch Of Med, Pediatrics; Montefiore M C-H&l Moses Div, Pediatrics | Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore) Program
Medical School: New York Univ Sch of Med, New York Ny | New York University School of Medicine
Is Dr. Bernstein board certified as a Pediatric Cardiologist?
Yes, Dr. Daniel Bernstein, MD is board certified by the American Board of Pediatrics
What languages does Dr. Bernstein speak?
Dr. Bernstein and their clinical team can communicate with patients in the following languages:
Chinese
English
Korean
Spanish
Tagalog
Vietnamese
What conditions does a Pediatric Cardiologist like Dr. Bernstein typically treat?
As a Pediatric Cardiologist, Dr. Bernstein diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Bernstein. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Tetralogy of Fallot
- Discordant Ventriculoarterial Connection
- Congenital Heart Defects
- Critical congenital heart disease
- TOF
- Blue Baby Syndrome
- Complex Heart Defect
- Transposition of the Great Arteries
- Congenital Heart Anomaly
- Heart Artery Misconnection
ICD-10 Codes:
- Q213: Tetralogy of Fallot
- Q203: Discordant ventriculoarterial connection
Also known as:
- Having a Heart Transplant
- Heart Transplantation
- Cardiac transplant
- Heart replacement surgery
- Post-heart transplant
ICD-10 Codes:
- Z941: Heart transplant status
What procedures does a Pediatric Cardiologist like Dr. Bernstein typically perform?
As a Pediatric Cardiologist, procedures performed by Dr. Daniel Bernstein may include:
- Absent Pulmonary Valve Repair
- Anomalous Coronary Artery Angiography
- Anticoagulation Management
- Aortic Stenosis Repair
- Aortic Valve Repair / Replacement
- Aortopulmonary Window Repair
- Arterial Doppler
- Balloon Septostomy
Please contact Dr. Bernstein's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Bernstein accept my insurance?
Dr. Bernstein accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Bernstein accept in Palo Alto, CA?
Dr. Bernstein in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
California Water Service Group
Community Health Network of Washington
CVS Health (formerly Aetna)
Kaiser Permanente
Molina Healthcare
Santa Cruz County
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Bernstein's office located?
Recognitions
Publications
Multi-institutiol Study of Outcomes After Pediatric Heart Transplantation
, 2014
Orthotopic heart transplantation in two infants with histiocytoid cardiomyopathy
, 2013
Deletion of the beta 2-adrenergic receptor prevents the development of cardiomyopathy in mice
, 2013
Lower socioeconomic status is associated with worse outcomes after both listing
, 2013
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
, 2013
Physiologic and molecular characterization of a murine model of right ventricular volume overload.
, 2013
Abdomil complaints as a common first presentation of heart failure
, 2013
Intermediate-term outcomes after combined heart
, 2013
Sacrificial layer technique for axial force post assay of immature cardiomyocytes
, 2013
Brg1 governs distinct pathways to direct multiple
, 2013
Loss of adenomatous poliposis coli
, 2012
Loss of Adenomatous Poliposis Coli
, 2012
Rel function and genetic polymorphisms in pediatric heart transplant recipients
, 2012
Outcomes of Children Following a First Hospitalization for Dilated Cardiomyopathy
, 2012
Dymic microR expression during the transition from right ventricular hypertrophy to failure
, 2012
Use of the Impella 5.0 as a bridge from ECMO to implantation of the HeartMate II left ventricular
, 2012
In Vivo Functiol and Transcriptiol Profiling of Bone Marrow Stem Cells After Transplantation Into
, 2012
Pharmacological inhibition of beta IIPKC is cardioprotective in late-stage hypertrophy
, 2011
beta 2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell
, 2011
Cardiac pressure overload hypertrophy is differentially regulated by beta
, 2011
Familial Cardiac Valvulopathy Due to Filamin A Mutation
, 2011
Gene Polymorphisms Impact the Risk of Rejection With Hemodymic Compromise: A Multicenter Study
, 2011
Calibrated micropost arrays for biomechanical characterisation of cardiomyocytes
, 2011
Clinical usefulness of a novel C1q
, 2011
NEW DIRECTIONS IN BASIC RESEARCH IN HYPERTROPHY AND HEART FAILURE
, 2011
THE ROLE OF ?-ADRENERGIC RECEPTORS IN HEART FAILURE
, 2011
Association of genetic polymorphisms
, 2010
Interagency Registry for Mechanically Assisted Circulatory Support
, 2010
Behcet's disease and heart transplantation: A word of caution
, 2010
Endogenous regulation of cardiovascular function by apelin-APJ
, 2009
Association of Left Ventricular Dilation at Listing for Heart Transplant With Postlisting
, 2009
Hypercholesterolemia impairs exercise capacity in mice
, 2009
Genotypic Variation and Phenotypic Characterization of Granzyme B Gene Polymorphisms
, 2009
Molecular and physiological characterization of RV remodeling in a murine model of pulmory stenosis
, 2008
Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation
, 2008
Prevention of pediatric graft corory artery disease: Atorvastatin
, 2008
Microsystems for biomechanical measurements
, 2008
Gene expression profiling distinguishes a molecular sigture
, 2007
Indications for heart transplantation in pediatric heart disease
, 2007
Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic
, 2006
Pediatric cardiac transplantation.
, 2006
Outcome of listing for cardiac transplantation for failed Fontan - A multi-institutiol study
, 2006
Neurologic events in neotes treated surgically for congenital heart disease
, 2006
Differential cardiotoxic/cardioprotective effects
, 2006
Ten- and 20-year survivors of pediatric orthotopic heart transplantation
, 2006
Effect of targeted deletions of beta(1)-
, 2006
Differential cardioprotective/cardiotoxic effects mediated by ss-adrenergic receptor subtypes
, 2005
Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmory hypertension
, 2005
Induction therapy for pediatric and adult heart transplantation
, 2005
Experience of percutaneous corory intervention
, 2005
The role of beta-adrenergic receptor sigling in cardioprotection.
, 2005
The role of beta-adrenergic receptor sigling in cardioprotection
, 2005
Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients
, 2005
The endogenous peptide apelin potently improves cardiac contractility
, 2005
Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic
, 2004
Intertiol society for heart and lung transplantation
, 2004
The mouse as a model of cardiovascular adaptations to microgravity
, 2004
Microarray alysis of gene expression after transverse aortic constriction in mice
, 2004
Linearity versus cross-talk
, 2004
Identifying cardiac transplant rejection in children
, 2004
Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience
, 2004
Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation
, 2003
Exercise assessment of transgenic models of human cardiovascular disease
, 2003
Efficacy and safety of atorvastatin after pediatric heart transplantation
, 2002
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
, 2002
Cardiovascular and metabolic alterations in mice lacking beta 1- and beta 2-adrenergic receptors
, 2002
Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients
, 2002
Infant heart transplantation at Stanford: Growth and neurodevelopmental outcome
, 2002
Survey of current practices in use of amiodarone
, 2001
L-Arginine enhances aerobic exercise capacity in association with augmented nitric oxide production
, 2001
Efficacy and safety of atorvastatin after pediatric cardiac transplantation.
, 2001
Outcome while awaiting heart transplantation in children
, 2000
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
, 2000
Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart
, 2000
The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation.
, 1999
Heart transplantation in children
, 1999
QT dispersion predicts ventricular arrhythmia
, 1999
Abnormal regulation of the sympathetic nervous system in alpha
, 1999
Targeted disruption of the beta 2 adrenergic receptor gene
, 1999
Cardiovascular and metabolic alterations in mice lacking both beta 1-and beta 2
, 1999
American Pediatric Society Society for Pediatric Research code of responsible conduct of research
, 1999
Phospholamban deficiency does not compromise exercise capacity
, 1999
Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training
, 1999
Limb blood flow during exercise is dependent on nitric oxide
, 1998
Alterations in dymic heart rate control in the beta(1)-adrenergic receptor knockout mouse
, 1998
Elective transplant pneumonectomy
, 1998
The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2
, 1998
Survival and risk factors for death after cardiac transplantation in infants - A multi
, 1997
Predicting outcome after listing for heart transplantation in children
, 1997
Cardiovascular indexes in the mouse at rest and with exercise
, 1997
Developmental and afterload stress regulation of heat shock proteins in the ovine myocardium
, 1997
Cardiovascular regulation in mice lacking alpha(2)-adrenergic receptor subtypes b and c
, 1996
Targeted disruption of the mouse beta 1-adrenergic receptor gene
, 1996
CARDIAC TRANSPLANTATION FOR HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH SENGERS-SYNDROME
, 1995
COLCHICINE AND CYTOCHALASIN-B ENHANCE CYCLIC-AMP ACCUMULATION VIA POSTRECEPTOR ACTIONS
, 1995
ARTERIAL SWITCH AND RESECTION OF HEPATIC HEMANGIOENDOTHELIOMA
, 1995
Pediatric cardiac transplantation. The Stanford experience.
, 1994
SUCCESSFUL THROMBOLYSIS OF A THROMBOSED ST-JUDE MEDICAL MITRAL PROSTHESIS IN A 2-MONTH-OLD INFANT
, 1994
NEOPLASTIC DISORDERS AFTER PEDIATRIC HEART-TRANSPLANTATION
, 1993
Neoplastic disorders after pediatric heart transplantation.
, 1993
HEART-TRANSPLANTATION IN INFANCY
, 1993
PRIMARY STRUCTURE OF THE MOUSE BETA(1)-ADRENERGIC RECEPTOR GENE
, 1993
Update on cardiac transplantation in infants and children.
, 1993
ALTERATION IN GS-MEDIATED SIGL TRANSDUCTION IN S49 LYMPHOMA
, 1993
TRANSCRIPTIOL REGULATION OF LEFT-VENTRICULAR BETA-ADRENERGIC RECEPTORS DURING CHRONIC HYPOXIA
, 1992
CURRENT APPROACH TO HYPOPLASTIC LEFT HEART SYNDROME - PALLIATION, TRANSPLANTATION, OR BOTH
, 1992
CARDIAC GROWTH AFTER PEDIATRIC HEART-TRANSPLANTATION
, 1992
DECREASED SERUM INSULIN-LIKE GROWTH FACTOR
, 1992
ALTERATIONS IN POSTTAL INTESTIL FUNCTION DURING CHRONIC HYPOXEMIA
, 1992
HEART, HEART-LUNG, AND LUNG TRANSPLANTATION IN THE 1ST YEAR OF LIFE
, 1992
REGULATION OF ATRIAL AUTONOMIC RECEPTORS IN EXPERIMENTAL CYANOTIC HEART-DISEASE
, 1991
PEDIATRIC HEART-TRANSPLANTATION AT STANFORD - RESULTS OF A 15-YEAR EXPERIENCE
, 1991
EBSTEINS-ANOMALY APPEARING IN THE NEOTE - A NEW SURGICAL APPROACH
, 1991
COMPARATIVE CIRCULATORY EFFECTS OF ISOPROTERENOL AND DOPAMINE IN LAMBS WITH EXPERIMENTAL CYANOTIC
, 1991
Pediatric heart transplantation.
, 1990
DIFFERENTIAL REGULATION OF RIGHT AND LEFT-VENTRICULAR BETA
, 1990
HEART-TRANSPLANTATION IN CHILDREN
, 1989